NCT03607539 2026-05-11Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCInnovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed397 enrolled 15 charts
NCT05024968 2026-02-25Sintilimab in Cancer of Unknown PrimaryM.D. Anderson Cancer CenterPhase 2 Completed10 enrolled 9 charts